Journal profile
RNA & DISEASE
ISSN 2375-2467 · Smart Science & Technology LLC · United States
RNA & DISEASE: diamond open access (no APC); no APC; review about 6 weeks (community reports); 0 articles in 2025.
The latest issue on the journal's website is from 2023 (Volume 10): the journal may have stopped publishing or moved platform in the last two years. Check its website before submitting.
Scope
Aims, scope and focus
RNA & DISEASE is published by Smart Science & Technology LLC. By OpenAlex counts of its recent articles, its largest topics are MicroRNA in disease regulation, Cancer-related molecular mechanisms research and RNA Research and Splicing, together about 50.5% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
RNA & DISEASE (Electronic ISSN: 2375-2467) is an open access, peer-reviewed, online journal that encompasses all basic and translational research of RNA in normal and pathological conditions. The editorial office of RNA & DISEASE is based at and sponsored by the First Affiliated Hospital of Nanjing Medical University.
From the journal's Aims & Scope
Editor-in-chief Naoyuki KataokaPublisher website
Editorial board by country: 2 in mainland China (about 40%); most named Mainland China 2, Japan 2, South Korea 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology27.1%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology14.3%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology9.1%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5.2%
- RNA regulation and diseaseBiochemistry, Genetics and Molecular Biology4.8%
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology4.3%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology3.3%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 10OpenAlex ·
- i10-index
- 11OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 102 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 9 |
| 2025 | 0 | 0 | 20 |
| 2024 | 0 | 0 | 26 |
| 2023 | 1 | 1 | 35 |
| 2022 | 1 | 1 | 46 |
| 2021 | 0 | 0 | 47 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 weeksLetPub ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 350 words
- Keywords
- 3–10
- Reference style
- AMA
Article types accepted2
- original research articleThis journal only accepts original research article and review.Length not stated
- reviewThis journal only accepts original research article and review.Length not stated
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, License & copyright, Open access
- Conflicts of interest
References must be marked as [1] in the body and follow AMA format. Model summary
The reference numbers in the body of manuscript must be marked as [1] and should be consistent with journal style (i.e. AMA format).
Source ↗Publisher website ·- Publication ethics
Ethical approval from institution should be disclosed. Model summary
Ethical approval from institution should be disclosed in this section.
Source ↗Publisher website ·- License & copyright
Creative Commons Attribution 4.0 International License Model summary
Published by the Smart Science & Technology LLC, USA under a Creative Commons Attribution 4.0 International License
Source ↗Publisher website ·- Open access
Funding agency and funding number should be disclosed. Model summary
Funding agency and funding number should be disclosed in this section.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Smart Science & Technology LLC
- Country or region
- United States
- Language
- English
- ISSN
- 2375-2467
- Latest issue on the website
- Volume 10 (2023)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about RNA & DISEASE
How long does peer review take at RNA & DISEASE?
Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of RNA & DISEASE?
According to the journal's author guidelines: Abstract: ≤ 350 words; Keywords: 3–10; Reference style: AMA. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of RNA & DISEASE based?
Of the 5 board members whose country the journal's board page names, 2 (about 40%) are in mainland China; the countries named most often are Mainland China (2), Japan (2) and South Korea (1). Counted from the institutions listed on the board page; for reference only.
Which databases index RNA & DISEASE?
According to LetPub and DOAJ records, RNA & DISEASE is indexed in DOAJ.
Is RNA & DISEASE open access, and what is the APC?
RNA & DISEASE is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .